News Foley Represents TCGX as Investor in Tourmaline Bio, Concurrent with Merger with Talaris Therapeutics Foley & Lardner LLP represented TCGX as an investor in the $75 million private placement…Louis LehotJanuary 24, 2024
News Foley Represents TCGX as Co-Lead Investor in $150M Series B Financing for Alkeus Pharmaceuticals Foley & Lardner LLP represented TCGX as co-lead investor in the $150 million Series B…Louis LehotJanuary 23, 2024
News Foley Represents NEA as Lead Investor in Comanche Biopharma Series B Round Foley & Lardner LLP recently represented New Enterprise Associates, Inc. (NEA) as lead investor in…Louis LehotJanuary 18, 2024
News Foley Serves as Legal Adviser to knownwell in $20M Series A Funding Foley & Lardner LLP served as legal adviser to knownwell, an in-person and virtual weight-inclusive…Von BryantDecember 21, 2023
Blogs AI in Health Care: Powering Patient Outcomes With the Health Care & Life Sciences sector under pressure to improve patient outcomes while…Foley IgniteDecember 11, 2023
Blogs 2024 Predictions: Unveiling the future of healthcare mergers and acquisitions This originally appeared in MobiHealthNews on December 8, 2023. Reprinted with permission. Today, a tale of two…Nate LacktmanDecember 8, 2023
Blogs Current Look at Digital Health There have been exciting advancements in the digital health space over the past few years…Louis LehotNovember 20, 2023
Blogs The Importance of ESG for Startups: Pioneering a Sustainable Future Partners Louis Lehot and Michael Kirwan published an article in Reuters Legal News titled: “The Importance of…Louis LehotSeptember 29, 2023
News Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension Foley & Lardner LLP represented Bioluminescence Ventures as the lead investor in the $50 million…Louis LehotSeptember 27, 2023
Blogs Key Takeaways for Directors on How to Harness the Power of AI in Health Care Foley & Lardner LLP recently co-hosted a webinar with the National Association of Corporate Directors…Louis LehotSeptember 21, 2023